tiprankstipranks
Advertisement
Advertisement
BioCryst backs FY26 revenue view $635M-$660M, consensus $650.22M
PremiumThe FlyBioCryst backs FY26 revenue view $635M-$660M, consensus $650.22M
1M ago
BioCryst Earnings Call: Growth, Pipeline And New Risks
Premium
Company Announcements
BioCryst Earnings Call: Growth, Pipeline And New Risks
1M ago
BioCryst Buy Rating Reiterated on Orladeyo Strength, Long-Term Growth Potential and Unchanged $30 Price Target
Premium
Ratings
BioCryst Buy Rating Reiterated on Orladeyo Strength, Long-Term Growth Potential and Unchanged $30 Price Target
1M ago
3 ‘Perfect 10’ Smart Score Stocks to Buy this Week, 4/13/26, According to Analysts
PremiumMarket News3 ‘Perfect 10’ Smart Score Stocks to Buy this Week, 4/13/26, According to Analysts
2M ago
BioCryst price target raised to $14 from $13 at RBC Capital
Premium
The Fly
BioCryst price target raised to $14 from $13 at RBC Capital
2M ago
BioCryst appoints Sandeep Menon as chief research and development officer
Premium
The Fly
BioCryst appoints Sandeep Menon as chief research and development officer
2M ago
Brand Risks Emerge in BioCryst’s ORLADEYO Sale to Neopharmed as Fragmented Positioning Threatens Long‑Term Value
PremiumCompany AnnouncementsBrand Risks Emerge in BioCryst’s ORLADEYO Sale to Neopharmed as Fragmented Positioning Threatens Long‑Term Value
4M ago
BioCryst Earnings Call Highlights Profits, Pipeline Momentum
Premium
Company Announcements
BioCryst Earnings Call Highlights Profits, Pipeline Momentum
4M ago
BioCryst Boosts HAE Franchise With Astria Acquisition, Guidance
Premium
Company Announcements
BioCryst Boosts HAE Franchise With Astria Acquisition, Guidance
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100